Preservica
30.1.2024 15:12:31 CET | ACCESS Newswire | Press release
GSK Selects Preservica Enterprise for its Corporate Archive, Ushering in a New Era of Digital Asset Resilience and Accessibility in Pharmaceuticals
BOSTON, MA and OXFORD, UK / ACCESSWIRE / January 30, 2024 / Preservica, a global leader in Active Digital Preservation™ archiving, is thrilled to announce GSK (GlaxoSmithKline), a multinational pharmaceutical and biotechnology company, has officially chosen Preservica as its Digital Preservation and archiving supplier for their Corporate Heritage Archives.
As a global leader in uniting science, technology and talent, GSK opted for Preservica's Enterprise edition with Active Digital Preservation™, ensuring not only the secure storage of historical records but also the continuous management, accessibility and protection of critical corporate governance and compliance documents in a way that goes beyond conventional archiving solutions.
The choice of Digital Preservation reflects a strategic decision to ensure the accessibility, integrity and longevity of these records. By leveraging Preservica, GSK not only fulfills its archival needs but also establishes a foundation to inform and protect the future of the business, offering valuable insights for strategic decision-making and ensuring a robust framework for regulatory compliance and brand continuity.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.GSK employee working in tuberculosis imaging laboratory at Tres Cantos site, Madrid
"After a comprehensive evaluation of preservation solutions, we confidently selected Preservica," said Jill Moretto, Senior Information Governance and Heritage Archive Manager. "Preservica automates our content migration workflows and also integrates seamlessly with our collections management system, Qi. Overall, it's simplifying our processes and eliminating duplicative work for the GSK Heritage team. This streamlined workflow is instrumental in documenting our contributions and legacy in health, science, industry, culture and the community, showcasing our impact on a global scale. Preservica completes GSK Heritage's core needs as a corporate archive. I'm so excited to use it to protect our legacy as we continue to get ahead of disease together."
Preservica Enterprise solution seamlessly integrates all essential elements for successful Digital Preservation, including public and secure access. The Enterprise edition not only meets but exceeds core requirements, offering a singular, integrated application that delivers comprehensive, scalable and fully compliant protection for critical long-term assets.
"This partnership stands as a testament to Preservica's commitment to advancing digital preservation standards across industries," said Preservica CEO, Mike Quinn. "Preservica is proud to contribute to the resilience and longevity of digital assets in an arena where historical data integrity directly influences advancements in healthcare and pharmaceutical breakthroughs."
The collaboration focuses on bolstering internal and external communications, as well as supporting marketing initiatives through the preservation of diverse file formats, including AV, TIFF, JPEG and standard office formats.
For more information on how Preservica is part of an international community of pharmaceutical institutions worldwide that are choosing Preservica as their trusted partner for Digital Preservation, visit preservica.com.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Find out more at gsk.com.
About Preservica
Preservica is transforming the way organizations around the world protect and future-proof critical long-term digital information. Available in the cloud (SaaS) or on-premise, our award-winning Active Digital Preservation™ archiving software has been designed from the ground up to tackle the unique challenges of ensuring digital information remains accessible and trustworthy over decades.
It's a proven solution that's trusted by thousands of businesses, archives, libraries, museums and government organizations around the world, including the UK National Archives, Texas State Library and Archives, MoMA, Yale and HSBC.
preservica.com
Twitter: @Preservica
LinkedIn: @Preservica
Media Contact:
Aleeza Goodman
York IE
aleeza@york.ie
SOURCE: Preservica
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Frame Security Launches KnowBetter as AI Reshapes Social Engineering8.7.2026 14:00:00 CEST | Press release
AI Is Rewriting the Social Engineering Playbook. Security Awareness Training Hasn't Caught Up. Organizations must KnowBetter. NEW YORK CITY, NY / ACCESS Newswire / July 8, 2026 / Security teams have spent two decades training employees to spot a familiar set of red flags: a suspicious link, a misspelled domain, an urgent request for a wire transfer. That approach is now colliding with an attacker toolkit that has changed faster than most awareness programs have. Generative AI has made it possible to clone a voice from a few seconds of audio, generate a passable deepfake video in minutes, and write a phishing email tailored to a specific employee's role, manager, and recent LinkedIn activity. Vishing calls, smishing texts, and video-based impersonation are now standard components of enterprise social engineering campaigns, not edge cases. "Most organizations are still training people to recognize threats from five years ago," said Tal Shlomo, co-founder and CEO of Frame Security, a huma
GoodData.AI Brings Governed Agentic Analytics to Regulated Enterprises Across DACH8.7.2026 13:05:00 CEST | Press release
GoodData.AI lets regulated enterprises in Germany, Austria, and Switzerland build and govern AI agents that support business processes, while maintaining full control over where AI runs and what data it can access. SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2026 / GoodData.AI, an open agentic analytics platform with nearly two decades of analytics experience, today announced an expanded investment in the DACH region, bringing governed agentic analytics to regulated enterprises across Germany, Austria, and Switzerland. Many regulated enterprises have held off on production AI because outputs can't be traced back to approved business logic. GoodData.AI's platform addresses that directly: agents stay on a process over time, drafting and updating reports, analyses, and recommendations as new data comes in, while every output stays grounded in logic the company has already approved and can show an auditor on request. The EU AI Act has introduced some of the most comprehensive AI governan
Polaris Announces Execution of Mixed Investment Agreement for the Three Mexico Projects7.7.2026 13:50:00 CEST | Press release
TORONTO, ON / ACCESS Newswire / July 7, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce that, further to its press release dated June 8, 2026, it has reached another important milestone in the development of its three renewable energy projects selected under Mexico's Comisión Federal de Electricidad ("CFE") Mixed Development Program (the "Mixed Program"). On July 3, 2026, Polaris, through its Mexican project structure, executed the Mixed Investment Agreement (Contrato de Inversión Mixta or "CIM") with the fiduciary trustee, Banca Mifel, S.A., Institucion de Banca Multiple, Grupo Financiero Mifel, acting on behalf of CFE. The CIM establishes the contractual 30-year framework governing the joint participation of Polaris and CFE in the development, financing, construction, ownership and operation of the three selected projects, including the applicable governance, economic and corporate arrangements. The CIM includes the key information a
Oxford University Press Comes to Simply Piano7.7.2026 10:00:00 CEST | Press release
Content from OUP's acclaimed piano method is now available to millions of Simply Piano learners worldwide NEW YORK, NY / ACCESS Newswire / July 7, 2026 / Simply, the leading digital platform for creative hobbies, today announced an agreement to bring content from Oxford University Press' (OUP) piano method to Simply Piano. This expands Simply Piano's offering and marks a step forward in its mission to make the pursuit of creative hobbies simple and fun for all. Simply Piano users around the world will gain access to an expanded library of high-quality, curated sheet music spanning OUP's works including Piano Time and Tunes for Ten Fingers, all within the app's interactive learning environment. The integration expands Simply Piano's sheet music library across genres, complementing its step-by-step courses and real-time feedback tools. "Access to songs people love is one of the strongest drivers of learning," said Yuval Kaminka, CEO & co-founder of Simply. "Working with OUP allows us to
AM Technical Solutions Acquires Sequence, Inc., Expanding Life Sciences Engineering and Commissioning, Qualification, and Validation (CQV) Capabilities7.7.2026 07:00:00 CEST | Press release
KILDARE, IRELAND / ACCESS Newswire / July 7, 2026 / AM Technical Solutions (AM), a global architecture, engineering, construction, and commissioning firm specializing in high-technology markets, announces the acquisition of Sequence, Inc., a leading engineering firm specializing in Process Design, Commissioning, Qualification, and Validation (CQV) solutions for life sciences and related high-tech industries. Sequence, headquartered in Morrisville, North Carolina, brings deep expertise in CQV, Computer System Validation (CSV), IT/OT integration, operational readiness, and life sciences engineering excellence. Their cross-functional approach to process engineering and facility startup has earned them a strong track record accelerating time to market for pharmaceutical and biopharmaceutical clients across the full project lifecycle -- from conceptual design through licensure and commercial operations. This acquisition deepens AM's existing Engineering and CQV capabilities with proven team
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom